(2026). MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy. Journal of Molecular Neuroscience.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy."
Journal of Molecular Neuroscience 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy."
Journal of Molecular Neuroscience, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.